PandemieGrippaleV1, Ncbi, Curation, bibRecord, 001D38

Booster influenza vaccination confers additional immune responses in an elderly, rural community-dwelling population.

Identifieur interne : 001D38 ( Ncbi/Curation ); précédent : 001D37; suivant : 001D39

Booster influenza vaccination confers additional immune responses in an elderly, rural community-dwelling population.

Auteurs : Masahide Matsushita [Japon] ; Seisho Takeuchi [Japon] ; Naoko Kumagai [Japon] ; Masaaki Morio [Japon] ; Chise Matsushita [Japon] ; Kazumi Arise [Japon] ; Toshihide Awatani [Japon]

Source :

American journal of infection control [ 1527-3296 ] ; 2018.

RBID : pubmed:29150194

Descripteurs français

English descriptors

KwdEn :
- Aged, Aged, 80 and over, Aging (immunology), Female, Humans, Immunization, Secondary, Influenza A Virus, H3N2 Subtype (immunology), Influenza B virus (classification), Influenza B virus (immunology), Influenza Pandemic, 1918-1919, Influenza Vaccines (immunology), Male, Middle Aged.
MESH :
- chemical , immunology : Influenza Vaccines.
- classification : Influenza B virus.
- immunology : Aging, Influenza A Virus, H3N2 Subtype, Influenza B virus.
- Aged, Aged, 80 and over, Female, Humans, Immunization, Secondary, Influenza Pandemic, 1918-1919, Male, Middle Aged.

Abstract

This study aimed to examine the effects of a booster vaccination in elderly people using 2 doses of trivalent inactivated influenza vaccine during the 2012-2013 influenza epidemic. Seroprotection rates against the A(H1N1)pdm09 strain in younger elderly people (aged 61-75 years) and the A(H3N2) and B strains in both younger elderly people (aged 61-75 years) as well as very elderly people (aged 76-102 years) did not decrease at 22 weeks after vaccination. This approach confers long-lasting antibody responses and may be useful in clinical practice.

DOI: 10.1016/j.ajic.2017.09.034
PubMed: 29150194

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000353
to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000353
to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000311
to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001D38

Links to Exploration step

pubmed:29150194

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Booster influenza vaccination confers additional immune responses in an elderly, rural community-dwelling population.</title>
<author><name sortKey="Matsushita, Masahide" sort="Matsushita, Masahide" uniqKey="Matsushita M" first="Masahide" last="Matsushita">Masahide Matsushita</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Family Medicine, Kochi Medical School, Nankoku, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Family Medicine, Kochi Medical School, Nankoku</wicri:regionArea>
<wicri:noRegion>Nankoku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Takeuchi, Seisho" sort="Takeuchi, Seisho" uniqKey="Takeuchi S" first="Seisho" last="Takeuchi">Seisho Takeuchi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of General Medicine, Kochi Medical School, Nankoku, Japan; Department of Infection Control and Prevention, Kochi Medical School, Nankoku, Japan. Electronic address: takeuti@kochi-u.ac.jp.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of General Medicine, Kochi Medical School, Nankoku, Japan; Department of Infection Control and Prevention, Kochi Medical School, Nankoku</wicri:regionArea>
<wicri:noRegion>Nankoku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kumagai, Naoko" sort="Kumagai, Naoko" uniqKey="Kumagai N" first="Naoko" last="Kumagai">Naoko Kumagai</name>
<affiliation wicri:level="1"><nlm:affiliation>Clinical Trial Center, Kochi Medical School, Nankoku, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Clinical Trial Center, Kochi Medical School, Nankoku</wicri:regionArea>
<wicri:noRegion>Nankoku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Morio, Masaaki" sort="Morio, Masaaki" uniqKey="Morio M" first="Masaaki" last="Morio">Masaaki Morio</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Family Medicine, Kochi Medical School, Nankoku, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Family Medicine, Kochi Medical School, Nankoku</wicri:regionArea>
<wicri:noRegion>Nankoku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Matsushita, Chise" sort="Matsushita, Chise" uniqKey="Matsushita C" first="Chise" last="Matsushita">Chise Matsushita</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Ohsugi Central Hospital, Ohtoyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Internal Medicine, Ohsugi Central Hospital, Ohtoyo</wicri:regionArea>
<wicri:noRegion>Ohtoyo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Arise, Kazumi" sort="Arise, Kazumi" uniqKey="Arise K" first="Kazumi" last="Arise">Kazumi Arise</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infection Control and Prevention, Kochi Medical School, Nankoku, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Infection Control and Prevention, Kochi Medical School, Nankoku</wicri:regionArea>
<wicri:noRegion>Nankoku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Awatani, Toshihide" sort="Awatani, Toshihide" uniqKey="Awatani T" first="Toshihide" last="Awatani">Toshihide Awatani</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Family Medicine, Kochi Medical School, Nankoku, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Family Medicine, Kochi Medical School, Nankoku</wicri:regionArea>
<wicri:noRegion>Nankoku</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29150194</idno>
<idno type="pmid">29150194</idno>
<idno type="doi">10.1016/j.ajic.2017.09.034</idno>
<idno type="wicri:Area/PubMed/Corpus">000353</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000353</idno>
<idno type="wicri:Area/PubMed/Curation">000353</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000353</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000311</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000311</idno>
<idno type="wicri:Area/Ncbi/Merge">001D38</idno>
<idno type="wicri:Area/Ncbi/Curation">001D38</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Booster influenza vaccination confers additional immune responses in an elderly, rural community-dwelling population.</title>
<author><name sortKey="Matsushita, Masahide" sort="Matsushita, Masahide" uniqKey="Matsushita M" first="Masahide" last="Matsushita">Masahide Matsushita</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Family Medicine, Kochi Medical School, Nankoku, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Family Medicine, Kochi Medical School, Nankoku</wicri:regionArea>
<wicri:noRegion>Nankoku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Takeuchi, Seisho" sort="Takeuchi, Seisho" uniqKey="Takeuchi S" first="Seisho" last="Takeuchi">Seisho Takeuchi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of General Medicine, Kochi Medical School, Nankoku, Japan; Department of Infection Control and Prevention, Kochi Medical School, Nankoku, Japan. Electronic address: takeuti@kochi-u.ac.jp.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of General Medicine, Kochi Medical School, Nankoku, Japan; Department of Infection Control and Prevention, Kochi Medical School, Nankoku</wicri:regionArea>
<wicri:noRegion>Nankoku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kumagai, Naoko" sort="Kumagai, Naoko" uniqKey="Kumagai N" first="Naoko" last="Kumagai">Naoko Kumagai</name>
<affiliation wicri:level="1"><nlm:affiliation>Clinical Trial Center, Kochi Medical School, Nankoku, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Clinical Trial Center, Kochi Medical School, Nankoku</wicri:regionArea>
<wicri:noRegion>Nankoku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Morio, Masaaki" sort="Morio, Masaaki" uniqKey="Morio M" first="Masaaki" last="Morio">Masaaki Morio</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Family Medicine, Kochi Medical School, Nankoku, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Family Medicine, Kochi Medical School, Nankoku</wicri:regionArea>
<wicri:noRegion>Nankoku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Matsushita, Chise" sort="Matsushita, Chise" uniqKey="Matsushita C" first="Chise" last="Matsushita">Chise Matsushita</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Ohsugi Central Hospital, Ohtoyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Internal Medicine, Ohsugi Central Hospital, Ohtoyo</wicri:regionArea>
<wicri:noRegion>Ohtoyo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Arise, Kazumi" sort="Arise, Kazumi" uniqKey="Arise K" first="Kazumi" last="Arise">Kazumi Arise</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infection Control and Prevention, Kochi Medical School, Nankoku, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Infection Control and Prevention, Kochi Medical School, Nankoku</wicri:regionArea>
<wicri:noRegion>Nankoku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Awatani, Toshihide" sort="Awatani, Toshihide" uniqKey="Awatani T" first="Toshihide" last="Awatani">Toshihide Awatani</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Family Medicine, Kochi Medical School, Nankoku, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Family Medicine, Kochi Medical School, Nankoku</wicri:regionArea>
<wicri:noRegion>Nankoku</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">American journal of infection control</title>
<idno type="eISSN">1527-3296</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Aging (immunology)</term>
<term>Female</term>
<term>Humans</term>
<term>Immunization, Secondary</term>
<term>Influenza A Virus, H3N2 Subtype (immunology)</term>
<term>Influenza B virus (classification)</term>
<term>Influenza B virus (immunology)</term>
<term>Influenza Pandemic, 1918-1919</term>
<term>Influenza Vaccines (immunology)</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémie de grippe de 1918-1919</term>
<term>Rappel de vaccin</term>
<term>Sous-type H3N2 du virus de la grippe A (immunologie)</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Vieillissement (immunologie)</term>
<term>Virus influenza B ()</term>
<term>Virus influenza B (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Influenza B virus</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H3N2 du virus de la grippe A</term>
<term>Vaccins antigrippaux</term>
<term>Vieillissement</term>
<term>Virus influenza B</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Aging</term>
<term>Influenza A Virus, H3N2 Subtype</term>
<term>Influenza B virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Immunization, Secondary</term>
<term>Influenza Pandemic, 1918-1919</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémie de grippe de 1918-1919</term>
<term>Rappel de vaccin</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Virus influenza B</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This study aimed to examine the effects of a booster vaccination in elderly people using 2 doses of trivalent inactivated influenza vaccine during the 2012-2013 influenza epidemic. Seroprotection rates against the A(H1N1)pdm09 strain in younger elderly people (aged 61-75 years) and the A(H3N2) and B strains in both younger elderly people (aged 61-75 years) as well as very elderly people (aged 76-102 years) did not decrease at 22 weeks after vaccination. This approach confers long-lasting antibody responses and may be useful in clinical practice.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D38 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001D38 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:29150194
   |texte=   Booster influenza vaccination confers additional immune responses in an elderly, rural community-dwelling population.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:29150194" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021

	Serveur d'exploration sur les pandémies grippales
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les pandémies grippales

Booster influenza vaccination confers additional immune responses in an elderly, rural community-dwelling population.

Booster influenza vaccination confers additional immune responses in an elderly, rural community-dwelling population.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki